IT1306141B1 - Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche. - Google Patents

Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.

Info

Publication number
IT1306141B1
IT1306141B1 IT1999RM000309A ITRM990309A IT1306141B1 IT 1306141 B1 IT1306141 B1 IT 1306141B1 IT 1999RM000309 A IT1999RM000309 A IT 1999RM000309A IT RM990309 A ITRM990309 A IT RM990309A IT 1306141 B1 IT1306141 B1 IT 1306141B1
Authority
IT
Italy
Prior art keywords
treatment
forms
vitamin
deprured
composition
Prior art date
Application number
IT1999RM000309A
Other languages
English (en)
Inventor
Giampiero Valletta
Original Assignee
Giampiero Valletta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giampiero Valletta filed Critical Giampiero Valletta
Publication of ITRM990309A0 publication Critical patent/ITRM990309A0/it
Priority to IT1999RM000309A priority Critical patent/IT1306141B1/it
Priority to EA200101205A priority patent/EA003792B1/ru
Priority to AT00935465T priority patent/ATE286396T1/de
Priority to EP00935465A priority patent/EP1178801B1/en
Priority to ES00935465T priority patent/ES2233384T3/es
Priority to JP2000617885A priority patent/JP2002544225A/ja
Priority to CA002373296A priority patent/CA2373296C/en
Priority to DE60017251T priority patent/DE60017251T2/de
Priority to US10/009,225 priority patent/US7026319B1/en
Priority to PCT/IT2000/000196 priority patent/WO2000069426A2/en
Priority to CNB008075948A priority patent/CN1159013C/zh
Priority to AU51003/00A priority patent/AU774343B2/en
Publication of ITRM990309A1 publication Critical patent/ITRM990309A1/it
Application granted granted Critical
Publication of IT1306141B1 publication Critical patent/IT1306141B1/it
Priority to US11/342,903 priority patent/US7291625B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
IT1999RM000309A 1999-05-17 1999-05-17 Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche. IT1306141B1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT1999RM000309A IT1306141B1 (it) 1999-05-17 1999-05-17 Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
CA002373296A CA2373296C (en) 1999-05-17 2000-05-17 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
US10/009,225 US7026319B1 (en) 1999-05-17 2000-05-17 Use of vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation
EP00935465A EP1178801B1 (en) 1999-05-17 2000-05-17 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
ES00935465T ES2233384T3 (es) 1999-05-17 2000-05-17 Combinacion de acido nicotinico o nicotinamida con riboflavina para el tratamiento de trastornos que conllevan prurito, picor e inflamacion.
JP2000617885A JP2002544225A (ja) 1999-05-17 2000-05-17 そう痒症及びかゆみ及び／又は炎症を伴う非感染性疾病の治療のためのビタミンの組合せの使用
EA200101205A EA003792B1 (ru) 1999-05-17 2000-05-17 Применение комбинации витаминов для лечения зуда и неинфекционных заболеваний, приводящих к зуду и/или воспалению
DE60017251T DE60017251T2 (de) 1999-05-17 2000-05-17 Kombination der nikotinsäure oder nikotinamid mit riboflavin für die behandlung der pruritus und entzündungstörungen
AT00935465T ATE286396T1 (de) 1999-05-17 2000-05-17 Kombination der nikotinsäure oder nikotinamid mit riboflavin für die behandlung der pruritus und entzündungstörungen
PCT/IT2000/000196 WO2000069426A2 (en) 1999-05-17 2000-05-17 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
CNB008075948A CN1159013C (zh) 1999-05-17 2000-05-17 合并使用维生素用于治疗搔痒症和涉及搔痒和/或炎症的非感染性疾病
AU51003/00A AU774343B2 (en) 1999-05-17 2000-05-17 Use of a vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation
US11/342,903 US7291625B2 (en) 1999-05-17 2006-01-30 Use of a vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000309A IT1306141B1 (it) 1999-05-17 1999-05-17 Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.

Publications (3)

Publication Number Publication Date
ITRM990309A0 ITRM990309A0 (it) 1999-05-17
ITRM990309A1 ITRM990309A1 (it) 2000-11-17
IT1306141B1 true IT1306141B1 (it) 2001-05-30

Family

ID=11406769

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999RM000309A IT1306141B1 (it) 1999-05-17 1999-05-17 Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.

Country Status (12)

Country Link
US (2) US7026319B1 (it)
EP (1) EP1178801B1 (it)
JP (1) JP2002544225A (it)
CN (1) CN1159013C (it)
AT (1) ATE286396T1 (it)
AU (1) AU774343B2 (it)
CA (1) CA2373296C (it)
DE (1) DE60017251T2 (it)
EA (1) EA003792B1 (it)
ES (1) ES2233384T3 (it)
IT (1) IT1306141B1 (it)
WO (1) WO2000069426A2 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1320776B1 (it) * 2000-08-07 2003-12-10 Giampiero Valletta Composizione farmaceutica a base di un'associazione vitaminica per laterapia delle cefalee primarie
ATE409037T1 (de) * 2001-03-08 2008-10-15 Univ Kentucky Res Found Verfahren zur erhöhung der leptinspiegel unter verwendung von nikotinsäureverbindungen
AR041089A1 (es) * 2003-05-15 2005-05-04 Merck & Co Inc Procedimiento y composiciones farmaceutiicas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
US20040254202A1 (en) * 2003-06-13 2004-12-16 The Procter & Gamble Company Method of promoting sleep using topical administration of vasoactive agents
WO2008097535A2 (en) * 2007-02-08 2008-08-14 Merck & Co., Inc. Method of treating atherosclerosis, dyslipidemias and related conditions
PT2271342E (pt) * 2008-03-28 2012-11-15 Elanco Animal Health Ireland Uso de nicotinamida para tratar o prurido de verão em cavalos
US8128949B2 (en) * 2008-04-14 2012-03-06 John Mosher Kit for insect bites
KR20180021280A (ko) * 2016-08-18 2018-03-02 한양대학교 산학협력단 리보플라빈을 포함하는 가려움증 억제 또는 완화용 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096712A1 (en) * 1970-06-29 1972-02-25 Giraux Georges Steroid/b group vitamin compsns - for prevention and treatment of skin-photosensitivity disorders
US4265887A (en) * 1979-12-11 1981-05-05 Breskman Joseph S Composition and method for treatment of hemorrhoids
US4619829A (en) 1982-11-16 1986-10-28 Georges Motschan Utilization of a single vitamin or a combination of various vitamins
US5053396A (en) * 1985-08-27 1991-10-01 Blass David H Therapeutic composition
JPS63188627A (ja) * 1987-01-31 1988-08-04 Rooto Seiyaku Kk 抗アレルギ−・抗炎症剤
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
CN1080855A (zh) 1993-05-22 1994-01-19 黎均耀 维生素矿物质防癌复方
DE4410238A1 (de) * 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
US5496827A (en) * 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
KR100414490B1 (ko) * 1995-07-13 2004-04-30 바스프 악티엔게젤샤프트 이소시트레이트리아제활성이변성된미생물에의한리보플라빈의제조방법
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
US6248763B1 (en) * 1998-05-19 2001-06-19 Scivoletto Rosemarie Composition for treating skin conditions
ATE306274T1 (de) * 1997-11-24 2005-10-15 Zhongming Zeng Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis
CA2322587A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions for regulating skin appearance

Also Published As

Publication number Publication date
ES2233384T3 (es) 2005-06-16
CA2373296A1 (en) 2000-11-23
US7026319B1 (en) 2006-04-11
EP1178801A2 (en) 2002-02-13
EP1178801B1 (en) 2005-01-05
CN1350455A (zh) 2002-05-22
EA003792B1 (ru) 2003-10-30
CN1159013C (zh) 2004-07-28
AU5100300A (en) 2000-12-05
WO2000069426A2 (en) 2000-11-23
US20060178368A1 (en) 2006-08-10
EA200101205A1 (ru) 2002-04-25
JP2002544225A (ja) 2002-12-24
DE60017251D1 (de) 2005-02-10
CA2373296C (en) 2008-07-15
WO2000069426A3 (en) 2001-04-12
ATE286396T1 (de) 2005-01-15
ITRM990309A1 (it) 2000-11-17
ITRM990309A0 (it) 1999-05-17
DE60017251T2 (de) 2005-12-15
AU774343B2 (en) 2004-06-24
US7291625B2 (en) 2007-11-06

Similar Documents

Publication Publication Date Title
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
DE602005009745D1 (de) Glucopyranosyl-substituierte benzen-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
BR0314059A (pt) Compostos heterocìclicos
MX2007000036A (es) Antagonistas del receptor 2 de citocina quimioatrayente de sales cuaternarias.
DK1474395T3 (da) Nicotinamidderivater, der er nyttige som p38-inhibitorer
ATE422198T1 (de) Arylsulfonylnaphthalinderivate als 5ht2a- antagonisten
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
NO20053046D0 (no) 4-okso-1(3-substituerte fenyl-1,4-dihydro-1,8-naftyridin-3-karboksamidfosfodiesterase-4-inhibitorer.
DE60221969D1 (de) Durch piperidine-enthaltende gruppen substituierte chinoline und deren stickstoff-enthaltende derivate und ihre verwendung als antibakterielle wirkstoffe
DE60305052D1 (de) Thienopyrrolyl und furanopyrrolyl verbindungen und deren verwendung als histamin h4 rezeptor liganden
NO20070855L (no) Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer.
NO20062417L (no) N-tiazol-2-yl-benzamidderivater
NO20051844L (no) Piperazinderivater og fremgangsmate for anvendelse derav.
NO20064706L (no) Thyroid reseptor agonister
NO20071574L (no) Arylsulfonylstilbenderivater for behandling av insomni og beslektede tilstander.
NO20080033L (no) Kinolinderivater som NK3-antagonister
IT1306141B1 (it) Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
NO20072060L (no) 2-acylaminotiazolderivater
ATE361306T1 (de) 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-(3.2.2 - nonanderivate, deren herstellung und deren therapeutische verwendung
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
NO20002655L (no) 5-(2-imidazolinylamino) -benzimidazol derivater, fremstilling og anvendelse derav som <alfa>-adrenoceptoragonister med forbedret metabolisk stabilitet
EA200602081A1 (ru) Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7
TW375610B (en) Novel substituent N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
MXPA03000887A (es) Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.